Reply to López-Campos et al. and to Rogliani and Calzetta

por Martinez, Fernando J., Darken, Patrick
Publicado en Am J Respir Crit Care Med (2021)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility an...

por Muro, Shigeo, Sugiura, Hisatoshi, Darken, Patrick, Dorinsky, Paul
Publicado en Respir Res (2021)

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe CO...

por Reisner, Colin, Pearle, James, Kerwin, Edward M, Rose, Earl St, Darken, Patrick
Publicado en Int J Chron Obstruct Pulmon Dis (2018)

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with mode...

por Kerwin, Edward M, Siler, Thomas M, Arora, Samir, Darken, Patrick, Rose, Earl, Reisner, Colin
Publicado en Int J Chron Obstruct Pulmon Dis (2018)

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic an...

por Siddiqui, Mohd Kashif, Shukla, Pragya, Jenkins, Martin, Ouwens, Mario, Guranlioglu, Deniz, Darken, Patrick, Biswas, Mousumi
Publicado en Ther Adv Respir Dis (2019)

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis o...

por Martinez, Fernando J, Ferguson, Gary T, Bourne, Eric, Ballal, Shaila, Darken, Patrick, Aurivillius, Magnus, Dorinsky, Paul, Reisner, Colin
Publicado en Int J Chron Obstruct Pulmon Dis (2021)

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agon...

por Ferguson, Gary T., Darken, Patrick, Ballal, Shaila, Siddiqui, Mohd Kashif, Singh, Barinder, Attri, Sumeet, Holmgren, Ulf, de Nigris, Enrico
Publicado en Adv Ther (2020)

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmo...

por Rennard, Stephen, Fogarty, Charles, Reisner, Colin, Fernandez, Carlos, Fischer, Tracy, Golden, Michael, Rose, Earl St, Darken, Patrick, Tardie, Gregory, Orevillo, Chadwick
Publicado 2014

Association between COPD exacerbations and lung function decline during maintenance therapy

por Kerkhof, Marjan, Voorham, Jaco, Dorinsky, Paul, Cabrera, Claudia, Darken, Patrick, Kocks, Janwillem WH, Sadatsafavi, Mohsen, Sin, Don D, Carter, Victoria, Price, David B
Publicado en Thorax (2020)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline

por Kerkhof, Marjan, Voorham, Jaco, Dorinsky, Paul, Cabrera, Claudia, Darken, Patrick, Kocks, Janwillem W H, Sadatsafavi, Mohsen, Sin, Don D, Carter, Victoria, Price, David B
Publicado en Int J Chron Obstruct Pulmon Dis (2020)

Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose...

por Sethi, Sanjay, Fogarty, Charles, Hanania, Nicola A., Martinez, Fernando J., Rennard, Stephen, Orevillo, Chad, Darken, Patrick, St. Rose, Earl, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Publicado en Chronic Obstr Pulm Dis (2016)

Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomi...

por Sethi, Sanjay, Fogarty, Charles, Hanania, Nicola A., Martinez, Fernando J., Rennard, Stephen, Orevillo, Chad, Darken, Patrick, St. Rose, Earl, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Publicado en Chronic Obstr Pulm Dis (2017)

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-...

por Martinez, Fernando J., Rabe, Klaus F., Ferguson, Gary T., Wedzicha, Jadwiga A., Singh, Dave, Wang, Chen, Rossman, Kimberly, St. Rose, Earl, Trivedi, Roopa, Ballal, Shaila, Darken, Patrick, Aurivillius, Magnus, Reisner, Colin
Publicado en Am J Respir Crit Care Med (2021)

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

por Fabbri, Leonardo M., Kerwin, Edward M., Spangenthal, Selwyn, Ferguson, Gary T., Rodriguez-Roisin, Roberto, Pearle, James, Sethi, Sanjay, Orevillo, Chad, Darken, Patrick, St. Rose, Earl, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Publicado en Respir Res (2016)

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Deliv...

por Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Publicado en Respir Res (2017)

Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspe...

por Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Publicado en Respir Res (2017)